SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001047469-18-003543
Filing Date
2018-05-07
Accepted
2018-05-07 17:09:50
Documents
3
Period of Report
2018-06-07

Document Format Files

Seq Description Document Type Size
1 PRE 14A a2235617zpre14a.htm PRE 14A 145981
2 G128492BGI001.GIF g128492bgi001.gif GRAPHIC 90512
3 G128492BGI002.GIF g128492bgi002.gif GRAPHIC 111504
  Complete submission text file 0001047469-18-003543.txt   425535
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36020 | Film No.: 18812124
SIC: 2834 Pharmaceutical Preparations